GMED
GLOBUS MEDICAL INC
Company overview
- Market capitalization
- $10.04B
- Employees
- 6,000
- Latest publication
- 2026-09-29
About GLOBUS MEDICAL INC
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 789,612,000USD | 759,854,000USD | 826,389,000USD | 769,048,000USD | 745,342,000USD | 598,121,000USD | 657,293,000USD | 625,705,000USD |
| Cost Of Revenue | 241,439,000USD | 234,066,000USD | 231,262,000USD | 282,376,000USD | 248,765,000USD | 195,397,000USD | 263,437,000USD | 270,515,000USD |
| Gross Profit | 548,173,000USD | 525,788,000USD | 595,127,000USD | 486,672,000USD | 496,577,000USD | 402,724,000USD | 393,856,000USD | 355,190,000USD |
| Research Development | 36,321,000USD | 36,510,000USD | 73,917,000USD | 38,067,000USD | 39,954,000USD | 33,062,000USD | 33,408,000USD | 35,380,000USD |
| Selling General Administrative | 286,823,000USD | 297,775,000USD | 318,480,000USD | 313,597,000USD | 303,622,000USD | 242,799,000USD | 253,481,000USD | 240,738,000USD |
| Total Operating Expenses | 365,741,000USD | 363,811,000USD | 423,448,000USD | 351,664,000USD | 420,468,000USD | 305,720,000USD | 333,582,000USD | 307,092,000USD |
| Operating Income | 182,432,000USD | 163,571,000USD | 171,679,000USD | 135,008,000USD | 76,109,000USD | 97,004,000USD | 60,274,000USD | 48,098,000USD |
| Total Other Income Expense Net | 7,385,000USD | -6,497,000USD | 2,386,000USD | 8,986,000USD | 112,064,000USD | 6,664,000USD | -35,607,000USD | 8,934,000USD |
| Income Before Tax | 189,817,000USD | 157,074,000USD | 174,065,000USD | 143,994,000USD | 188,173,000USD | 103,668,000USD | 24,667,000USD | 57,032,000USD |
| Income Tax Expense | 38,248,000USD | 32,772,000USD | 33,439,000USD | 25,028,000USD | -14,673,000USD | 28,206,000USD | -1,838,000USD | 5,196,000USD |
| Net Income | 151,569,000USD | 124,302,000USD | 140,626,000USD | 118,966,000USD | 202,846,000USD | 75,462,000USD | 26,505,000USD | 51,836,000USD |
| Net Income Applicable To Common Shares | 151,569,000USD | — | — | — | — | — | — | — |
| Unclassified Operating Expenses | — | 29,526,000USD | 31,051,000USD | — | 76,892,000USD | 29,859,000USD | 46,693,000USD | 30,974,000USD |
| Interest Expense | — | 5,434,000USD | — | 1,455,000USD | 693,000USD | — | 815,000USD | 775,000USD |
| Net Interest Income | — | 5,434,000USD | 3,312,000USD | 1,455,000USD | 693,000USD | 1,681,000USD | 815,000USD | -775,000USD |
| Tax Provision | — | 32,772,000USD | 28,639,000USD | 25,028,000USD | -14,673,000USD | 28,206,000USD | -1,838,000USD | 5,196,000USD |
| Net Income From Continuing Ops | — | 124,302,000USD | 140,594,000USD | 118,966,000USD | 202,846,000USD | 75,462,000USD | 26,505,000USD | 51,836,000USD |
| Ebit | — | 157,074,000USD | 174,065,000USD | 143,994,000USD | 122,812,000USD | 98,061,000USD | 77,055,000USD | 48,996,000USD |
| Ebitda | — | 226,930,000USD | 244,392,000USD | 215,120,000USD | 193,443,000USD | 164,135,000USD | 145,283,000USD | 115,943,000USD |
| Depreciation And Amortization | — | 69,856,000USD | 70,327,000USD | 71,126,000USD | 70,631,000USD | 66,074,000USD | 68,228,000USD | 66,947,000USD |
| Reconciled Depreciation | — | 69,856,000USD | 69,011,000USD | 71,126,000USD | 70,631,000USD | 66,074,000USD | 68,228,000USD | 66,947,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,938,900,000USD | 2,519,355,000USD | 1,568,476,000USD | 1,022,843,000USD | 958,102,000USD | 789,042,000USD | 785,368,000USD | 712,969,000USD |
| Cost Of Revenue | 957,800,000USD | 1,035,479,000USD | 548,174,000USD | 263,725,000USD | 239,223,000USD | 217,463,000USD | 179,975,000USD | 159,410,000USD |
| Gross Profit | 1,981,100,000USD | 1,483,876,000USD | 1,020,302,000USD | 759,118,000USD | 718,879,000USD | 571,579,000USD | 605,393,000USD | 553,559,000USD |
| Research Development | 185,000,000USD | 163,754,000USD | 124,010,000USD | 73,015,000USD | 97,346,000USD | 84,519,000USD | 60,073,000USD | 55,496,000USD |
| Selling General Administrative | 1,178,498,000USD | 981,048,000USD | 643,410,000USD | 432,117,000USD | 408,149,000USD | 354,757,000USD | 354,757,000USD | 311,591,000USD |
| Unclassified Operating Expenses | 137,802,000USD | 173,083,000USD | 119,740,000USD | 26,035,000USD | 41,431,000USD | 20,870,000USD | 18,574,000USD | 17,147,000USD |
| Total Operating Expenses | 1,501,300,000USD | 1,317,885,000USD | 887,160,000USD | 531,167,000USD | 546,926,000USD | 460,146,000USD | 433,404,000USD | 384,234,000USD |
| Operating Income | 479,800,000USD | 165,991,000USD | 133,142,000USD | 227,951,000USD | 171,953,000USD | 111,433,000USD | 171,989,000USD | 169,325,000USD |
| Net Interest Income | 7,141,000USD | -4,189,000USD | 20,130,000USD | 14,233,000USD | 9,297,000USD | 13,952,000USD | 17,406,000USD | 13,278,000USD |
| Income Before Tax | 609,900,000USD | 120,722,000USD | 165,393,000USD | 243,019,000USD | 180,407,000USD | 125,899,000USD | 189,946,000USD | 188,605,000USD |
| Income Tax Expense | 72,000,000USD | 17,738,000USD | 42,520,000USD | 52,850,000USD | 31,216,000USD | 23,614,000USD | 34,736,000USD | 32,131,000USD |
| Tax Provision | 67,200,000USD | 17,738,000USD | 42,520,000USD | 52,850,000USD | 31,216,000USD | 23,614,000USD | 34,736,000USD | 32,131,000USD |
| Net Income | 537,900,000USD | 102,984,000USD | 122,873,000USD | 190,169,000USD | 149,191,000USD | 102,285,000USD | 155,210,000USD | 156,474,000USD |
| Net Income From Continuing Ops | 537,868,000USD | 102,984,000USD | 122,873,000USD | 190,169,000USD | 149,191,000USD | 102,285,000USD | 155,210,000USD | 156,474,000USD |
| Ebit | 609,900,000USD | 219,701,000USD | 201,850,000USD | 236,251,000USD | 194,858,000USD | 115,472,000USD | 176,754,000USD | 176,884,000USD |
| Ebitda | 729,900,000USD | 473,725,000USD | 346,583,000USD | 304,503,000USD | 264,725,000USD | 178,346,000USD | 229,488,000USD | 218,514,000USD |
| Depreciation And Amortization | 120,000,000USD | 254,024,000USD | 144,733,000USD | 68,252,000USD | 69,867,000USD | 62,874,000USD | 52,734,000USD | 41,630,000USD |
| Reconciled Depreciation | 276,842,000USD | 254,024,000USD | 144,733,000USD | 68,252,000USD | 69,867,000USD | 62,874,000USD | 52,734,000USD | 41,630,000USD |
| Total Other Income Expense Net | 130,100,000USD | -45,269,000USD | 32,251,000USD | 15,068,000USD | 8,454,000USD | 14,466,000USD | 17,957,000USD | 19,280,000USD |
| Interest Expense | — | 4,189,000USD | 20,130,000USD | 14,233,000USD | 9,297,000USD | 13,952,000USD | 17,406,000USD | 13,278,000USD |
| Non Operating Income Net Other | — | — | — | 15,068,000USD | 8,454,000USD | 14,466,000USD | — | 19,280,000USD |
| Net Income Applicable To Common Shares | — | — | — | 190,169,000USD | 149,191,000USD | 102,285,000USD | 155,210,000USD | 156,474,000USD |
| Interest Income | — | — | — | — | — | — | 17,481,000USD | 13,638,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,488,258,000USD | 5,439,555,000USD | 5,302,761,000USD | 5,095,640,000USD | 4,961,089,000USD | 4,711,148,000USD | 5,251,750,000USD | 5,086,044,000USD |
| Cash And Equivalents | 507,745,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 595,142,000USD | 629,851,000USD | 557,243,000USD | 390,523,000USD | 229,446,000USD | 461,266,000USD | 890,057,000USD | 694,706,000USD |
| Short Term Investments | 87,397,000USD | 68,901,000USD | 31,087,000USD | 18,754,000USD | 0USD | 0USD | 105,619,000USD | 71,940,000USD |
| Long Term Investments | 245,358,000USD | 169,437,000USD | 71,819,000USD | 16,684,000USD | 0USD | 0USD | 66,134,000USD | 12,297,000USD |
| Total Current Assets | 2,215,512,000USD | 2,198,120,000USD | 2,125,611,000USD | 1,924,361,000USD | 1,729,902,000USD | 1,710,114,000USD | 2,177,260,000USD | 2,056,529,000USD |
| Other Current Assets | 70,195,000USD | 60,228,000USD | 65,426,000USD | 74,177,000USD | 68,202,000USD | 47,131,000USD | 49,640,000USD | 50,924,000USD |
| Other Non Current Assets | 79,238,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 719,655,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 479,347,000USD | 482,463,000USD | 498,499,000USD | 465,958,000USD | 424,664,000USD | 384,701,000USD | 855,913,000USD | 818,065,000USD |
| Other Current Liabilities | 300,728,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 19,046,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 4,768,603,000USD | 4,732,312,000USD | 4,573,250,000USD | 4,398,825,000USD | 4,295,683,000USD | 4,088,068,000USD | 4,177,333,000USD | 4,069,397,000USD |
| Total Equity Including Noncontrolling Interest | 4,768,603,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 27,981,000USD | — | — | — | — | — | — | — |
| Net Receivables | 692,176,000USD | 735,439,000USD | 743,665,000USD | 688,123,000USD | 660,123,000USD | 538,114,000USD | 578,330,000USD | 593,196,000USD |
| Inventory | 810,897,000USD | 772,602,000USD | 759,277,000USD | 771,538,000USD | 772,131,000USD | 663,603,000USD | 659,233,000USD | 717,703,000USD |
| Property Plant Equipment Net | 592,683,000USD | 618,646,000USD | 628,238,000USD | 637,202,000USD | 649,092,000USD | 604,863,000USD | 611,556,000USD | 620,646,000USD |
| Goodwill | 1,438,216,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 692,624,000USD | 720,845,000USD | 745,064,000USD | 773,902,000USD | 796,372,000USD | 771,688,000USD | 795,117,000USD | 842,778,000USD |
| Accounts Payable | 106,941,000USD | 103,658,000USD | 98,852,000USD | 87,227,000USD | 87,099,000USD | 73,144,000USD | 75,118,000USD | 57,537,000USD |
| Short Term Debt | 14,385,000USD | 15,121,000USD | 14,738,000USD | 14,355,000USD | 13,179,000USD | 10,622,000USD | 453,600,000USD | 448,182,000USD |
| Retained Earnings | 1,527,087,000USD | 1,512,259,000USD | 1,387,957,000USD | 1,292,485,000USD | 1,213,657,000USD | 1,036,173,000USD | 1,152,813,000USD | 1,126,308,000USD |
| Accumulated Other Comprehensive Income | 11,196,000USD | 14,404,000USD | 15,346,000USD | 10,927,000USD | 10,239,000USD | -2,167,000USD | -6,861,000USD | -6,963,000USD |
| Total Liab | — | 707,243,000USD | 729,511,000USD | 696,815,000USD | 665,406,000USD | 623,080,000USD | 1,074,417,000USD | 1,016,647,000USD |
| Other Current Liab | — | 334,305,000USD | 353,099,000USD | 346,109,000USD | 261,506,000USD | 234,318,000USD | 260,242,000USD | 244,889,000USD |
| Common Stock | — | 135,000USD | 135,000USD | 134,000USD | 135,000USD | 135,000USD | 137,000USD | 135,000USD |
| Capital Stock | — | 135,000USD | 135,000USD | 134,000USD | 135,000USD | 135,000USD | 137,000USD | 135,000USD |
| Good Will | — | 1,438,733,000USD | 1,435,033,000USD | 1,434,291,000USD | 1,434,983,000USD | 1,432,964,000USD | 1,432,387,000USD | 1,431,666,000USD |
| Cash | — | 560,950,000USD | 526,156,000USD | 371,769,000USD | 229,446,000USD | 461,266,000USD | 784,438,000USD | 622,766,000USD |
| Current Deferred Revenue | — | 26,347,000USD | 27,655,000USD | 18,267,000USD | 24,020,000USD | 17,172,000USD | 22,140,000USD | 20,802,000USD |
| Net Debt | — | -445,727,000USD | -407,500,000USD | -252,426,000USD | -108,342,000USD | -368,953,000USD | -247,250,000USD | -88,208,000USD |
| Short Long Term Debt Total | — | 115,223,000USD | 118,656,000USD | 119,343,000USD | 121,104,000USD | 92,313,000USD | 537,188,000USD | 534,558,000USD |
| Property Plant Equipment Gross | — | 1,366,228,000USD | 1,333,238,000USD | 1,283,866,000USD | 1,250,845,000USD | 1,176,591,000USD | 1,157,342,000USD | 1,126,628,000USD |
| Common Stock Shares Outstanding | — | 138,191,000shares | 137,219,388shares | 135,394,000shares | 136,499,000shares | 139,774,000shares | 139,711,000shares | 138,062,000shares |
| Non Current Assets Total | — | 3,241,435,000USD | 3,177,150,000USD | 3,171,279,000USD | 3,231,187,000USD | 3,001,034,000USD | 3,074,490,000USD | 3,029,515,000USD |
| Non Current Liabilities Total | — | 224,780,000USD | 231,012,000USD | 230,857,000USD | 240,742,000USD | 238,379,000USD | 218,504,000USD | 198,582,000USD |
| Non Current Liabilities Other | — | 100,020,000USD | 103,338,000USD | 103,331,000USD | 108,415,000USD | 110,083,000USD | 111,027,000USD | 104,731,000USD |
| Non Currrent Assets Other | — | 78,964,000USD | 78,781,000USD | 76,838,000USD | 74,843,000USD | 74,856,000USD | 75,096,000USD | 76,643,000USD |
| Net Working Capital | — | 1,715,657,000USD | 1,627,112,000USD | 1,458,403,000USD | 1,305,238,000USD | 1,325,413,000USD | 1,321,347,000USD | 1,238,464,000USD |
| Unclassified Non Current Assets | — | 214,810,000USD | 218,215,000USD | 232,362,000USD | 275,897,000USD | 116,663,000USD | 94,200,000USD | 45,485,000USD |
| Unclassified Non Current Liabilities | — | 124,760,000USD | 127,674,000USD | 127,526,000USD | 132,327,000USD | 128,296,000USD | 107,477,000USD | 93,851,000USD |
| Unclassified Equity | — | 3,205,379,000USD | 3,169,677,000USD | 3,095,145,000USD | 3,071,517,000USD | 3,053,792,000USD | 3,031,107,000USD | 2,949,782,000USD |
| Unclassified Current Liabilities | — | — | — | — | 38,860,000USD | 49,445,000USD | -398,538,000USD | -390,487,000USD |
| Short Long Term Debt | — | — | — | — | — | — | 443,351,000USD | 437,142,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,302,761,000USD | 5,251,750,000USD | 5,086,083,000USD | 2,076,126,000USD | 1,957,263,000USD | 1,679,485,000USD | 1,532,077,000USD | 1,300,670,000USD |
| Intangible Assets | 745,064,000USD | 795,117,000USD | 924,603,000USD | 63,574,000USD | 68,660,000USD | 86,949,000USD | 78,812,000USD | 87,323,000USD |
| Other Current Assets | 65,426,000USD | 49,640,000USD | 44,580,000USD | 20,997,000USD | 18,417,000USD | 17,771,000USD | 17,243,000USD | 15,487,000USD |
| Total Liab | 729,511,000USD | 1,074,417,000USD | 1,088,124,000USD | 229,753,000USD | 215,875,000USD | 173,188,000USD | 129,625,000USD | 115,154,000USD |
| Total Stockholder Equity | 4,573,250,000USD | 4,177,333,000USD | 3,997,959,000USD | 1,846,373,000USD | 1,741,388,000USD | 1,506,297,000USD | 1,402,452,000USD | 1,185,516,000USD |
| Other Current Liab | 353,099,000USD | 260,242,000USD | 277,769,000USD | 95,448,000USD | 98,723,000USD | 88,409,000USD | 75,334,000USD | 63,115,000USD |
| Common Stock | 135,000USD | 137,000USD | 136,000USD | 100,000USD | 101,000USD | 99,000USD | 99,000USD | 98,000USD |
| Capital Stock | 135,000USD | 137,000USD | 136,000USD | 100,000USD | 101,000USD | 99,000USD | 99,000USD | 98,000USD |
| Retained Earnings | 1,387,957,000USD | 1,152,813,000USD | 1,137,266,000USD | 1,239,951,000USD | 1,194,272,000USD | 1,045,082,000USD | 1,047,931,000USD | 892,721,000USD |
| Good Will | 1,435,033,000USD | 1,432,387,000USD | 1,434,540,000USD | 197,471,000USD | 179,708,000USD | 156,716,000USD | 128,775,000USD | 123,734,000USD |
| Cash | 526,156,000USD | 784,438,000USD | 467,292,000USD | 150,466,000USD | 193,069,000USD | 239,397,000USD | 195,724,000USD | 139,747,000USD |
| Cash And Short Term Investments | 557,243,000USD | 890,057,000USD | 517,789,000USD | 446,058,000USD | 443,447,000USD | 426,741,000USD | 311,487,000USD | 339,684,000USD |
| Total Current Assets | 2,125,611,000USD | 2,177,260,000USD | 1,915,374,000USD | 983,344,000USD | 864,516,000USD | 821,765,000USD | 687,468,000USD | 630,681,000USD |
| Total Current Liabilities | 498,499,000USD | 855,913,000USD | 392,347,000USD | 159,204,000USD | 140,164,000USD | 120,792,000USD | 111,403,000USD | 96,118,000USD |
| Current Deferred Revenue | 27,655,000USD | 22,140,000USD | 18,369,000USD | 14,100,000USD | 12,025,000USD | 8,125,000USD | 5,402,000USD | 2,598,000USD |
| Net Debt | -407,500,000USD | -247,250,000USD | 53,112,000USD | -144,455,000USD | -193,069,000USD | -239,397,000USD | -195,724,000USD | -139,647,000USD |
| Short Term Debt | 14,738,000USD | 453,600,000USD | 11,967,000USD | 2,536,000USD | 94,414,000USD | 88,685,000USD | 74,660,000USD | 4,510,000USD |
| Short Long Term Debt Total | 118,656,000USD | 537,188,000USD | 520,404,000USD | 6,011,000USD | 5,053,000USD | 4,801,000USD | 2,481,000USD | — |
| Long Term Investments | 71,819,000USD | 66,134,000USD | 75,428,000USD | 495,852,000USD | 562,475,000USD | 358,522,000USD | 409,514,000USD | 263,117,000USD |
| Short Term Investments | 31,087,000USD | 105,619,000USD | 50,497,000USD | 295,592,000USD | 250,378,000USD | 187,344,000USD | 115,763,000USD | 199,937,000USD |
| Net Receivables | 743,665,000USD | 578,330,000USD | 504,870,000USD | 217,308,000USD | 165,651,000USD | 148,100,000USD | 162,424,000USD | 144,356,000USD |
| Inventory | 759,277,000USD | 659,233,000USD | 848,135,000USD | 298,981,000USD | 237,001,000USD | 229,153,000USD | 196,314,000USD | 131,254,000USD |
| Accounts Payable | 98,852,000USD | 75,118,000USD | 56,671,000USD | 36,101,000USD | 21,955,000USD | 18,205,000USD | 24,614,000USD | 25,895,000USD |
| Property Plant Equipment Net | 628,238,000USD | 611,556,000USD | 646,863,000USD | 243,729,000USD | 221,076,000USD | 216,879,000USD | 199,841,000USD | 171,873,000USD |
| Property Plant Equipment Gross | 1,333,238,000USD | 1,157,342,000USD | 1,072,558,000USD | 586,765,000USD | 526,651,000USD | 216,879,000USD | 199,841,000USD | 171,873,000USD |
| Accumulated Other Comprehensive Income | 15,346,000USD | -6,861,000USD | -10,192,000USD | -24,630,000USD | -6,772,000USD | 3,955,000USD | -2,898,000USD | -7,172,000USD |
| Common Stock Shares Outstanding | 137,219,388shares | 137,863,000shares | 114,630,000shares | 102,643,000shares | 103,623,000shares | 100,971,000shares | 101,998,000shares | 101,316,000shares |
| Non Current Assets Total | 3,177,150,000USD | 3,074,490,000USD | 3,170,709,000USD | 1,092,782,000USD | 1,092,747,000USD | 857,720,000USD | 844,609,000USD | 669,989,000USD |
| Non Current Liabilities Total | 231,012,000USD | 218,504,000USD | 695,777,000USD | 70,549,000USD | 75,711,000USD | 52,396,000USD | 18,222,000USD | 19,036,000USD |
| Non Current Liabilities Other | 103,338,000USD | 111,027,000USD | 102,919,000USD | 68,770,000USD | 71,397,000USD | 46,194,000USD | 12,199,000USD | 10,922,000USD |
| Non Currrent Assets Other | 78,781,000USD | 75,096,000USD | 78,590,000USD | 43,311,000USD | 36,334,000USD | 32,039,000USD | 21,741,000USD | 10,364,000USD |
| Net Working Capital | 1,627,112,000USD | 1,321,347,000USD | 1,523,027,000USD | 824,140,000USD | 724,352,000USD | 700,973,000USD | 576,065,000USD | 534,563,000USD |
| Unclassified Non Current Assets | 218,215,000USD | 94,200,000USD | — | -43,311,000USD | -36,334,000USD | -203,217,000USD | -19,260,000USD | -10,364,000USD |
| Unclassified Non Current Liabilities | 127,674,000USD | 107,477,000USD | 175,458,000USD | -70,549,000USD | -75,711,000USD | -52,396,000USD | -11,057,000USD | -19,036,000USD |
| Unclassified Equity | 3,169,677,000USD | 3,031,107,000USD | 2,870,613,000USD | 630,852,000USD | 553,686,000USD | 457,062,000USD | 357,221,000USD | 299,771,000USD |
| Short Long Term Debt | — | 443,351,000USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | — | -398,538,000USD | 27,571,000USD | 11,019,000USD | -86,953,000USD | -82,632,000USD | -68,607,000USD | — |
| Long Term Debt | — | — | 417,400,000USD | — | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 1,779,000USD | 4,314,000USD | 6,202,000USD | — | 8,114,000USD |
| Other Liab | — | — | — | 70,549,000USD | 75,711,000USD | 52,396,000USD | 17,080,000USD | 19,036,000USD |
| Other Assets | — | — | — | 92,156,000USD | 60,828,000USD | 209,832,000USD | 25,186,000USD | 23,942,000USD |
| Net Tangible Assets | — | — | — | 1,585,328,000USD | 1,493,020,000USD | 1,262,632,000USD | 1,194,865,000USD | 974,459,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 139,355,000USD |
| Stock Based Compensation | 26,000,000USD |
| Deferred Income Tax | 15,748,000USD |
| Change To Account Receivables | -27,211,000USD |
| Change To Inventory | -44,551,000USD |
| Change To Liabilities | -30,349,000USD |
| Change In Working Capital | -47,445,000USD |
| Operating Cash Flow | 412,105,000USD |
| Capital Expenditures | -72,783,000USD |
| Net Investments | -232,530,000USD |
| Other Investing Activities | -6,409,000USD |
| Investing Cash Flow | -311,722,000USD |
| Net Debt Issuance | -169,000USD |
| Net Common Stock Issuance | -139,511,000USD |
| Unclassified Financing Cash Flow | 23,381,000USD |
| Financing Cash Flow | -116,299,000USD |
| Effect Of Forex Changes On Cash | -2,495,000USD |
| Change In Cash | -18,411,000USD |
| End Cash Flow | 507,745,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 124,302,000USD | 140,594,000USD | 118,966,000USD | 202,846,000USD | 75,462,000USD | 26,505,000USD | 51,836,000USD | 31,760,000USD |
| Depreciation | 69,856,000USD | 70,327,000USD | 71,126,000USD | 70,631,000USD | 66,074,000USD | 68,228,000USD | 66,947,000USD | 63,588,000USD |
| Stock Based Compensation | 12,617,000USD | 11,418,000USD | 11,538,000USD | 13,617,000USD | 13,206,000USD | 11,907,000USD | 12,211,000USD | 12,813,000USD |
| Other Non Cash Items | 15,745,000USD | 45,574,000USD | 4,563,000USD | -110,856,000USD | 12,448,000USD | 109,613,000USD | 65,252,000USD | 83,238,000USD |
| Change To Account Receivables | -13,399,000USD | -64,153,000USD | -8,424,000USD | -2,208,000USD | 22,603,000USD | 22,483,000USD | 23,661,000USD | -87,813,000USD |
| Change To Inventory | -16,651,000USD | -178,000USD | -5,698,000USD | -4,135,000USD | -7,587,000USD | -11,887,000USD | 4,882,000USD | -13,869,000USD |
| Change In Working Capital | -28,118,000USD | -37,426,000USD | 1,741,000USD | -56,628,000USD | 9,601,000USD | 27,265,000USD | 34,856,000USD | -116,957,000USD |
| Total Cash From Operating Activities | 202,364,000USD | 248,587,000USD | 249,695,000USD | 77,865,000USD | 177,300,000USD | 210,339,000USD | 203,654,000USD | 54,258,000USD |
| Capital Expenditures | -39,615,000USD | -56,197,000USD | -30,817,000USD | -51,562,000USD | -41,103,000USD | -17,111,000USD | -41,952,000USD | -27,798,000USD |
| Free Cash Flow | 162,749,000USD | 192,390,000USD | 218,878,000USD | 26,303,000USD | 136,197,000USD | 193,228,000USD | 161,702,000USD | 26,460,000USD |
| Investments | -138,150,000USD | -65,172,000USD | -75,842,000USD | -299,108,000USD | 131,385,000USD | -104,122,000USD | -14,967,000USD | -10,378,000USD |
| Total Cashflows From Investing Activities | -182,674,000USD | -111,449,000USD | -75,842,000USD | -299,108,000USD | 131,385,000USD | -104,122,000USD | -14,967,000USD | -10,378,000USD |
| Net Borrowings | 0USD | 0USD | 0USD | 0USD | -449,985,000USD | — | — | — |
| Total Cash From Financing Activities | 18,197,000USD | 13,215,000USD | -32,042,000USD | -24,937,000USD | -635,396,000USD | 59,733,000USD | 19,583,000USD | 8,709,000USD |
| Sale Purchase Of Stock | 0USD | -45,000,000USD | -40,000,000USD | -25,000,000USD | -190,451,000USD | -1,000,000USD | 0USD | -1,471,000USD |
| Change In Cash | 34,794,000USD | 154,387,000USD | 142,323,000USD | -231,820,000USD | -323,172,000USD | 161,672,000USD | 212,342,000USD | 56,362,000USD |
| Begin Period Cash Flow | 526,156,000USD | 371,769,000USD | 229,446,000USD | 461,266,000USD | 784,438,000USD | 622,766,000USD | 410,424,000USD | 354,062,000USD |
| End Period Cash Flow | 560,950,000USD | 526,156,000USD | 371,769,000USD | 229,446,000USD | 461,266,000USD | 784,438,000USD | 622,766,000USD | 410,424,000USD |
| Other Cashflows From Investing Activities | -11,261,000USD | 247,228,000USD | -259,880,000USD | -5,000,000USD | -5,000,000USD | — | -26,243,000USD | 22,306,000USD |
| Other Cashflows From Financing Activities | -7,764,000USD | 58,215,000USD | -3,121,000USD | 63,000USD | 5,040,000USD | 60,733,000USD | 19,583,000USD | 10,180,000USD |
| Unclassified Operating Cash Flow | 7,962,000USD | 18,100,000USD | 41,761,000USD | -41,745,000USD | — | -33,179,000USD | -27,448,000USD | -20,184,000USD |
| Unclassified Investing Cash Flow | 6,352,000USD | -237,308,000USD | 290,697,000USD | 56,562,000USD | 46,103,000USD | 17,111,000USD | 68,195,000USD | 5,492,000USD |
| Unclassified Financing Cash Flow | 25,961,000USD | — | 11,079,000USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 537,868,000USD | 102,984,000USD | 122,873,000USD | 190,169,000USD | 149,191,000USD | 102,285,000USD | 155,210,000USD | 156,474,000USD |
| Depreciation | 276,842,000USD | 254,024,000USD | 144,733,000USD | 68,252,000USD | 69,867,000USD | 62,874,000USD | 52,734,000USD | 41,630,000USD |
| Stock Based Compensation | 49,779,000USD | 54,191,000USD | 52,742,000USD | 32,810,000USD | 30,586,000USD | 27,073,000USD | 26,085,000USD | 21,899,000USD |
| Other Non Cash Items | -46,955,000USD | 332,895,000USD | 97,538,000USD | 14,722,000USD | 61,497,000USD | 48,489,000USD | 7,088,000USD | 10,537,000USD |
| Change To Account Receivables | -52,182,000USD | -78,062,000USD | -49,914,000USD | -50,843,000USD | -25,895,000USD | 10,696,000USD | -18,306,000USD | -21,789,000USD |
| Change To Inventory | -17,598,000USD | -29,860,000USD | -70,328,000USD | -61,745,000USD | -11,971,000USD | -50,111,000USD | -50,018,000USD | -31,382,000USD |
| Change In Working Capital | -82,712,000USD | -97,554,000USD | -116,598,000USD | -105,262,000USD | -17,252,000USD | -37,590,000USD | -73,444,000USD | -49,868,000USD |
| Total Cash From Operating Activities | 753,447,000USD | 520,638,000USD | 243,499,000USD | 178,468,000USD | 276,274,000USD | 198,793,000USD | 171,975,000USD | 181,643,000USD |
| Capital Expenditures | -164,679,000USD | -115,429,000USD | -78,274,000USD | -74,047,000USD | -56,898,000USD | -63,658,000USD | -70,750,000USD | -59,697,000USD |
| Free Cash Flow | 588,768,000USD | 405,209,000USD | 165,225,000USD | 104,421,000USD | 219,376,000USD | 135,135,000USD | 101,225,000USD | 121,946,000USD |
| Investments | 71,957,000USD | -176,051,000USD | -78,131,000USD | -4,880,000USD | -284,553,000USD | -20,181,000USD | -45,732,000USD | -123,505,000USD |
| Total Cashflows From Investing Activities | -355,014,000USD | -176,051,000USD | 302,968,000USD | -110,362,000USD | -375,939,000USD | -117,322,000USD | -140,281,000USD | -193,027,000USD |
| Net Borrowings | -449,985,000USD | 0USD | 0USD | — | — | — | — | — |
| Total Cash From Financing Activities | -679,160,000USD | -27,696,000USD | -231,821,000USD | -109,962,000USD | 54,147,000USD | -38,663,000USD | 24,439,000USD | 32,570,000USD |
| Sale Purchase Of Stock | -300,451,000USD | -85,787,000USD | -225,562,000USD | -144,493,000USD | 63,496,000USD | -104,669,000USD | 31,036,000USD | 39,309,000USD |
| Change In Cash | -258,282,000USD | 317,146,000USD | 316,826,000USD | -42,603,000USD | -46,328,000USD | 43,673,000USD | 55,977,000USD | 20,930,000USD |
| Begin Period Cash Flow | 784,438,000USD | 467,292,000USD | 150,466,000USD | 193,069,000USD | 239,397,000USD | 195,724,000USD | 139,747,000USD | 118,817,000USD |
| End Period Cash Flow | 526,156,000USD | 784,438,000USD | 467,292,000USD | 150,466,000USD | 193,069,000USD | 239,397,000USD | 195,724,000USD | 139,747,000USD |
| Other Cashflows From Investing Activities | -275,754,000USD | -44,156,000USD | — | -4,880,000USD | -284,553,000USD | -20,181,000USD | -45,732,000USD | 35,000,000USD |
| Other Cashflows From Financing Activities | -378,709,000USD | 58,091,000USD | -6,259,000USD | 34,531,000USD | 54,147,000USD | 66,006,000USD | -6,597,000USD | -6,739,000USD |
| Unclassified Operating Cash Flow | 18,625,000USD | -125,902,000USD | -57,789,000USD | -22,223,000USD | -17,615,000USD | -4,338,000USD | 4,302,000USD | — |
| Unclassified Investing Cash Flow | 13,462,000USD | 159,585,000USD | 459,373,000USD | -26,555,000USD | 250,065,000USD | -13,302,000USD | 21,933,000USD | -44,825,000USD |
| Unclassified Financing Cash Flow | 449,985,000USD | — | — | — | -63,496,000USD | — | — | — |
| Change To Liabilities | — | — | — | 17,618,000USD | 26,792,000USD | 12,913,000USD | 773,000USD | 10,799,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -41,856,000USD | -45,518,000USD | 42,808,000USD | — | 20,930,000USD |
| Issuance Of Capital Stock | — | — | — | — | 63,496,000USD | 72,322,000USD | 31,036,000USD | 39,309,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -256,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | International | 170,507,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 619,105,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Enabling Technologies | 26,072,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Musculoskeletal Solutions | 763,540,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 154,966,000 | USD | 0001628280-26-032290 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 604,888,000 | USD | 0001628280-26-032290 |
| Q1 2026Quarterly · 2026-03-31 | Product | Enabling Technologies | 26,870,000 | USD | 0001628280-26-032290 |
| Q1 2026Quarterly · 2026-03-31 | Product | Musculoskeletal Solutions | 732,984,000 | USD | 0001628280-26-032290 |
| Q4 2025Quarterly · 2025-12-31 | Geography | International | 161,098,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 665,322,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 571,335,000 | USD | 0001628280-26-011209 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 2,367,596,000 | USD | 0001628280-26-011209 |
| FY 2025Yearly · 2025-12-31 | Product | Enabling Technologies | 141,008,000 | USD | 0001628280-26-011209 |
| FY 2025Yearly · 2025-12-31 | Product | Musculoskeletal Solutions | 2,797,923,000 | USD | 0001628280-26-011209 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 151,415,000 | USD | 0001237831-25-000031 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 617,633,000 | USD | 0001237831-25-000031 |
| Q3 2025Quarterly · 2025-09-30 | Product | Emerging Technology | 28,039,000 | USD | 0001237831-25-000031 |
| Q3 2025Quarterly · 2025-09-30 | Product | Spine | 741,009,000 | USD | 0001237831-25-000031 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 144,558,000 | USD | 0001562762-25-000200 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 600,784,000 | USD | 0001562762-25-000200 |
| Q2 2025Quarterly · 2025-06-30 | Product | Emerging Technology | 35,160,000 | USD | 0001562762-25-000200 |
| Q2 2025Quarterly · 2025-06-30 | Product | Spine | 710,182,000 | USD | 0001562762-25-000200 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 114,264,000 | USD | 0001628280-26-032290 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 483,857,000 | USD | 0001628280-26-032290 |
| Q1 2025Quarterly · 2025-03-31 | Product | Enabling Technologies | 22,189,000 | USD | 0001628280-26-032290 |
| Q1 2025Quarterly · 2025-03-31 | Product | Musculoskeletal Solutions | 575,932,000 | USD | 0001628280-26-032290 |
| Q4 2024Quarterly · 2024-12-31 | Geography | International | 135,401,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 521,892,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Emerging Technology | 46,953,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Spine | 610,340,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 519,288,000 | USD | 0001628280-26-011209 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 2,000,067,000 | USD | 0001628280-26-011209 |
| FY 2024Yearly · 2024-12-31 | Product | Enabling Technologies | 154,003,000 | USD | 0001628280-26-011209 |
| FY 2024Yearly · 2024-12-31 | Product | Musculoskeletal Solutions | 2,365,352,000 | USD | 0001628280-26-011209 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 129,916,000 | USD | 0001237831-25-000031 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 495,789,000 | USD | 0001237831-25-000031 |
| Q3 2024Quarterly · 2024-09-30 | Product | Emerging Technology | 38,303,000 | USD | 0001237831-25-000031 |
| Q3 2024Quarterly · 2024-09-30 | Product | Spine | 587,402,000 | USD | 0001237831-25-000031 |
| Q2 2024Quarterly · 2024-06-30 | Product | Emerging Technology | 36,778,000 | USD | 0001562762-25-000200 |
| Q2 2024Quarterly · 2024-06-30 | Product | Spine | 592,913,000 | USD | 0001562762-25-000200 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 288,711,000 | USD | 0001628280-26-011209 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 1,279,765,000 | USD | 0001628280-26-011209 |
| FY 2023Yearly · 2023-12-31 | Product | Enabling Technologies | 120,216,000 | USD | 0001628280-26-011209 |
| FY 2023Yearly · 2023-12-31 | Product | Musculoskeletal Solutions | 1,448,260,000 | USD | 0001628280-26-011209 |
| FY 2022Yearly · 2022-12-31 | Geography | International | 150,904,000 | USD | 0001562762-25-000026 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 871,939,000 | USD | 0001562762-25-000026 |
| FY 2022Yearly · 2022-12-31 | Product | Emerging Technology | 96,140,000 | USD | 0001562762-25-000026 |
| FY 2022Yearly · 2022-12-31 | Product | Spine | 926,703,000 | USD | 0001562762-25-000026 |
| FY 2021Yearly · 2021-12-31 | Geography | International | 138,531,000 | USD | 0001562762-24-000032 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 819,571,000 | USD | 0001562762-24-000032 |
| FY 2021Yearly · 2021-12-31 | Product | Emerging Technology | 81,322,000 | USD | 0001562762-24-000032 |
| FY 2021Yearly · 2021-12-31 | Product | Spine | 876,780,000 | USD | 0001562762-24-000032 |
| FY 2020Yearly · 2020-12-31 | Geography | International | 124,588,000 | USD | 0001562762-23-000048 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 664,454,000 | USD | 0001562762-23-000048 |
| FY 2020Yearly · 2020-12-31 | Product | Emerging Technology | 40,596,000 | USD | 0001562762-23-000048 |
| FY 2020Yearly · 2020-12-31 | Product | Spine | 748,446,000 | USD | 0001562762-23-000048 |
| FY 2019Yearly · 2019-12-31 | Geography | International | 137,685,000 | USD | 0001562762-22-000037 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 647,683,000 | USD | 0001562762-22-000037 |
| FY 2019Yearly · 2019-12-31 | Product | Emerging Technology | 46,991,000 | USD | 0001562762-22-000037 |
| FY 2019Yearly · 2019-12-31 | Product | Spine | 738,377,000 | USD | 0001562762-22-000037 |
| FY 2018Yearly · 2018-12-31 | Geography | International | 119,091,000 | USD | 0001562762-21-000036 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 593,878,000 | USD | 0001562762-21-000036 |
| FY 2018Yearly · 2018-12-31 | Product | Emerging Technology | 46,929,000 | USD | 0001562762-21-000036 |
| FY 2018Yearly · 2018-12-31 | Product | Spine | 666,040,000 | USD | 0001562762-21-000036 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.